<DOC>
	<DOC>NCT00174395</DOC>
	<brief_summary>To evaluate the efficacy of early intervention (dosing within 2 hours of onset of the migraine attack) with eletriptan 40mg on mild versus moderate to severe pain intensity of migraine.</brief_summary>
	<brief_title>A Trial to Study of the Effects of Eletriptan 40mg on Mild vs Moderate to Severe Pain Intensity of Migraine</brief_title>
	<detailed_description />
	<mesh_term>Migraine Disorders</mesh_term>
	<mesh_term>Eletriptan</mesh_term>
	<criteria>Diagnosis of migraine with or without aura according to the recent IHS criteria. Migraine headaches must have been present for more than one year. History in the last 3 months of 1 to 4 acute attacks of migraine headache per month. Subjects with current or past history of coronary artery disease. Pregnant or breastfeeding women. Subjects who have chronic daily headaches.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>October 2007</verification_date>
</DOC>